Mary E. Abood

Affiliations: 
Cell Biology Temple University, Philadelphia, PA, United States 
Area:
Molecular Biology, Pharmacology, Biochemistry
Google:
"Mary Abood"

Children

Sign in to add trainee
Jahan Marcu grad student 2013 Temple University
Thomas F. Gamage post-doc 2014-2016 Temple University (Neurotree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Leo LM, Abood ME. (2021) CB1 Cannabinoid Receptor Signaling and Biased Signaling. Molecules (Basel, Switzerland). 26
Garai S, Leo LM, Szczesniak AM, et al. (2021) Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy. Journal of Medicinal Chemistry
Morales P, Lago-Fernandez A, Hurst DP, et al. (2020) Therapeutic Exploitation of GPR18: Beyond the Cannabinoids? Journal of Medicinal Chemistry
Garai S, Kulkarni PM, Schaffer PC, et al. (2019) Application of Fluorine- And Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of CB1 Receptor Positive Allosteric Modulators. Journal of Medicinal Chemistry
Leo LM, Familusi B, Hoang M, et al. (2019) GPR55-mediated effects on brain microvascular endothelial cells and the blood-brain barrier. Neuroscience
Brailoiu E, Chakraborty S, Brailoiu GC, et al. (2019) Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP-Evoked Ca Signals through Sigma-1 Receptors. Cell Reports. 26: 330-337.e4
Brailoiu E, Barlow CL, Ramirez SH, et al. (2018) Effects of Platelet-Activating Factor on brain microvascular endothelial cells. Neuroscience
Bertini S, Chicca A, Gado F, et al. (2017) Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor. Bioorganic & Medicinal Chemistry
Brailoiu E, McGuire M, A Shuler S, et al. (2017) Modulation of cardiac vagal tone by bradykinin acting on nucleus ambiguus. Neuroscience
Howlett AC, Abood ME. (2017) CB1 and CB2 Receptor Pharmacology. Advances in Pharmacology (San Diego, Calif.). 80: 169-206
See more...